Doctrine Of Equivalents Trips Reddy’s And Pfizer On Pemetrexed
• By Aidan Fry
Using a vaguely similar, but not identical, salt form is enough to infringe, even if the patent identifies a specific salt, the US Court of Appeals says • Source: Shutterstock
Stay ahead of every shift in generics and biosimilars.
Generics Bulletin brings you the latest updates that matter for the off-patent industry.
